与良性疾病相比,子宫内膜癌不增加子宫切除术后30天静脉血栓栓塞风险:一项丹麦全国队列研究
该丹麦全国登记队列研究纳入2005—2014年因子宫内膜癌(5513例)或良性疾病(45825例)行子宫切除术的患者,随访术后30天。子宫内膜癌组30天VTE发生率为0.5%(30例),良性疾病组为0.16%(73例),总体发生率为0.2%(103/51338)。多因素分析显示,子宫内膜癌与良性疾病相比30天VTE的OR=1.47(95%CI 0.74-2.91,p=0.27),无统计学显著差异;开腹手术、淋巴结清扫、BMI>40和既往VTE是独立危险因素。
要点
- 子宫内膜癌与良性疾病相比,子宫切除术后30天VTE的OR=1.47(95%CI 0.74-2.91,p=0.27),无统计学显著差异。
- 开腹手术(微创vs开腹:OR=0.46,95%CI 0.30-0.71,p<0.001)、淋巴结清扫(OR=4.00,95%CI 1.89-8.46,p<0.001)、BMI>40(OR=2.34,95%CI 1.10-5.01,p=0.03)和既往VTE(OR=34,95%CI 22.7-51.3,p<0.001)是30天VTE的独立危险因素。
- 子宫内膜癌组30天VTE发生率为0.5%(30例),良性疾病组为0.16%(73例),总体为0.2%(103/51338)。
核心结论
- 本研究未发现子宫内膜癌是子宫切除术后VTE的独立危险因素(与良性疾病相比)。
- 开腹手术、淋巴结清扫、BMI>40和既往VTE被识别为术后30天VTE的独立危险因素。
研究设计与样本
- 全国登记为基础的队列研究,链接丹麦妇科癌症数据库(DGCD)和丹麦国家患者登记册(DNPR)与另外四个行政登记库。
- 纳入2005—2014年因子宫内膜癌或良性疾病行子宫切除术的患者,随访术后30天。
- 共纳入子宫内膜癌患者5513例和良性疾病患者45825例。
- 采用多因素logistic回归模型估计术后30天VTE的OR。
主要发现
- 子宫切除术后30天VTE总体发生率为0.2%(103/51338)。
- 子宫内膜癌组30天VTE发生率为0.5%(30例),良性疾病组为0.16%(73例)。
- 子宫内膜癌与良性疾病相比,30天VTE的OR=1.47(95%CI 0.74-2.91,p=0.27),无统计学显著差异。
- 微创手术与开腹手术相比,30天VTE的OR=0.46(95%CI 0.30-0.71,p<0.001)。
- 淋巴结清扫的30天VTE OR=4.00(95%CI 1.89-8.46,p<0.001);BMI>40的OR=2.34(95%CI 1.10-5.01,p=0.03);既往VTE的OR=34(95%CI 22.7-51.3,p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to clarify if endometrial cancer patients are at higher risk of venous thromboembolism (VTE) following hysterectomy, compared to patients undergoing hysterectomy for benign gynecological disease. METHODS: In a nationwide registry-based cohort study, patients undergoing hysterectomy for endometrial cancer or benign disease were followed 30 days after surgery. The Danish Gynecological Cancer Database (DGCD) and the Danish National Patient Register (DNPR) were linked with four other administrative registries to describe the population and retrieve data on venous thromboembolism and mortality. Multivariable logistic regression models were used to estimate odds ratios (ORs) for 30-day postoperative VTE. RESULTS: We identified 5513 patients with endometrial cancer, and 45,825 patients with benign disease undergoing hysterectomy in the period 2005-2014. The overall incidence of 30-day VTE following hysterectomy was 0.2% (103/51,338). Thirty (0.5%) patients with endometrial cancer and 73 (0.16%) patients with benign disease developed VTE. In a multivariable logistic regression analysis, significant predictors of 30-day OR for VTE were open surgery (minimally invasive surgery vs. open: OR = 0.46; 95% CI, 0.30-0.71; p < 0.001), lymphadenectomy (OR = 4.00; 95% CI, 1.89-8.46; p < 0.001), BMI > 40 (OR = 2.34;95% CI, 1.10-5.01; p = 0.03) and previous VTE (OR = 34; 95% CI, 22.7-51.3; p < 0.001). There was no statistically significant difference in the 30-day OR for VTE in endometrial cancer compared to benign disease (OR = 1.47; 95% CI, 0.74-2.91; p = 0.27). CONCLUSIONS: This study did not identify endometrial cancer to be an independent risk factor for VTE following hysterectomy compared to benign disease. We identified open surgery, lymphadenectomy, BMI above 40 and previous VTE as independent risk factors for 30-day postoperative VTE.
引用
- Kahr HS, Christiansen OB, Høgdall C, et al. Endometrial cancer does not increase the 30-day risk of venous thromboembolism following hysterectomy compared to benign disease. A Danish National Cohort Study. Gynecol Oncol. 2019. PMID: 31378374. doi:10.1016/j.ygyno.2019.07.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。